 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|
||||||||||||||||
| ||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thanks to Internet Technology you can now have access to affordable Estraderm without leaving the comfort of your home. A prior permission is NOT required but we do recommend you consult a physician before place Estraderm ordering. Order Estraderm drugs on Sale. Q. What countries do you Estraderm ship to? A. RxBrandMeds.net ships Estraderm to all countries. Q. Will my drugs be shipped in a discreet package? A. Yes! All goods, including Estraderm, are packaged discreetly. The Estraderm cannot be identified from the packaging. We do not include company logo's etc on the outside of the package. Q. Are USA, Canada, UK and Europe within your shipping range? A. Yes. We can ship Estraderm anywhere in the world. Q. When shall I receive my Estraderm order? A. We will ship Estraderm within 24 hours. Shipping using regular airmail takes between 7-14 days worldwide. Q. What is a brand name drug Estraderm? A. A brand name drug Estraderm is approved by the Food and Drug Administration (FDA), and is supplied by one company (the pharmaceutical manufacturer). The drug is protected by a patent and is marketed under the manufacturer's brand name. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treats the lack of estrogen from menopause or removal of the ovaries. Also used to treat osteoporosis (bone loss). Treats the lack of estrogen from menopause or removal of the ovaries. Also used to treat osteoporosis (bone loss). Treats the lack of estrogen from menopause or removal of the ovaries. Also used to treat osteoporosis (bone loss). Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Estraderm, estradiol transdermal system, is designed to release estradiol through a rate-limiting membrane continuously upon application to intact skin. EstradermR (estradiol transdermal system) is indicated in: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. 4. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risks of osteoporosis and non-estrogen medications should be carefully considered. The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin D intake, and when indicated, pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore, when not contraindicated, calcium supplementation may be helpful for women with suboptimal dietary intake. Vitamin D supplementation of 400-800 IU/day may also be required to ensure adequate daily intake in postmenopausal women. Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Estraderm, estradiol transdermal system, is designed to release estradiol through a rate-limiting membrane continuously upon application to intact skin. EstradermR (estradiol transdermal system) is indicated in: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. 4. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risks of osteoporosis and non-estrogen medications should be carefully considered. The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin D intake, and when indicated, pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore, when not contraindicated, calcium supplementation may be helpful for women with suboptimal dietary intake. Vitamin D supplementation of 400-800 IU/day may also be required to ensure adequate daily intake in postmenopausal women. Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Estraderm, estradiol transdermal system, is designed to release estradiol through a rate-limiting membrane continuously upon application to intact skin. EstradermR (estradiol transdermal system) is indicated in: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. 4. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risks of osteoporosis and non-estrogen medications should be carefully considered. The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin D intake, and when indicated, pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore, when not contraindicated, calcium supplementation may be helpful for women with suboptimal dietary intake. Vitamin D supplementation of 400-800 IU/day may also be required to ensure adequate daily intake in postmenopausal women. Treat symptoms of menopause such as hot flashes. Also used to treat breast cancer, prostate cancer, and other conditions. Treat symptoms of menopause such as hot flashes. Also used to treat breast cancer, prostate cancer, and other conditions. Treat symptoms of menopause such as hot flashes. Also used to treat breast cancer, prostate cancer, and other conditions. |
Products mentioned are trademarks of their respective companies
For medical advice, diagnoses, and treatment, consult your doctor.
Drugs without prescription